FCRL3 -169C/C genotype is associated with anti-citrullinated protein antibody-positive rheumatoid arthritis and with radiographic progression

Journal of Rheumatology

Volumn 38, Issue 11, 2011, Pages 2329-2335

  Maehlen, Marthe T ^a   Nordang, Gry B ^b   Syversen, Silje W ^a   Van Der Heijde, Désirée M ^c   Kvien, Tore K ^a   Uhlig, Till ^a   Lie, Benedicte A ^b  

^a DIAKONHJEMMET HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anticitrullinated protein antibodies; Genetic predisposition; Joint erosions; Rheumatoid arthritis; Single nucleotide polymorphism

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; PREDNISOLONE; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; AGE; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ERYTHROCYTE SEDIMENTATION RATE; FCRL3 GENE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAND RADIOGRAPHY; HUMAN; JOINT INJURY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NORWAY; PRIORITY JOURNAL; PROMOTER REGION; RHEUMATOID ARTHRITIS; SEX;

ADULT; ALLELES; ANTIBODIES, ANTI-IDIOTYPIC; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAND JOINTS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NORWAY; PEPTIDES, CYCLIC; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RECEPTORS, IMMUNOLOGIC; SEVERITY OF ILLNESS INDEX;

EID: 80155146623     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110489     Document Type: Article

References (33)

1. Marinou I, Maxwell JR, Wilson AG. Genetic influences modulating the radiological severity of rheumatoid arthritis. Ann Rheum Dis 2010;69:476-82.
2. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447:661-78.
3. Kochi Y, Yamada R, Suzuki A, Harley JB, Shirasawa S, Sawada T, et al. A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet 2005;37:478-85. (Pubitemid 40617275)
4. Eike MC, Nordang GB, Karlsen TH, Boberg KM, Vatn MH, Dahl-Jorgensen K, et al. The FCRL3 -169T>C polymorphism is associated with rheumatoid arthritis and shows suggestive evidence of involvement with juvenile idiopathic arthritis in a Scandinavian panel of autoimmune diseases. Ann Rheum Dis 2008;67:1287-91.
5. Thabet MM, Wesoly J, Slagboom PE, Toes RE, Huizinga TW. FCRL3 promoter 169 CC homozygosity is associated with susceptibility to rheumatoid arthritis in Dutch Caucasians. Ann Rheum Dis 2007;66:803-6. (Pubitemid 46846701)
6. Choi CB, Kang CP, Seong SS, Bae SC, Kang C. The -169C/T polymorphism in FCRL3 is not associated with susceptibility to rheumatoid arthritis or systemic lupus erythematosus in a case-control study of Koreans. Arthritis Rheum 2006;54:3838-41. (Pubitemid 44955885)
7. Eyre S, Bowes J, Potter C, Worthington J, Barton A. Association of the FCRL3 gene with rheumatoid arthritis: a further example of population specificity? Arthritis Res Ther 2006;8:R117.
8. Hu X, Chang M, Saiki RK, Cargill MA, Begovich AB, Ardlie KG, et al. The functional -169T->C single-nucleotide polymorphism in FCRL3 is not associated with rheumatoid arthritis in white North Americans. Arthritis Rheum 2006;54:1022-5.
9. Ikari K, Momohara S, Nakamura T, Hara M, Yamanaka H, Tomatsu T, et al. Supportive evidence for a genetic association of the FCRL3 promoter polymorphism with rheumatoid arthritis. Ann Rheum Dis 2006;65:671-3.
10. Owen CJ, Kelly H, Eden JA, Merriman ME, Pearce SH, Merriman TR. Analysis of the Fc receptor-like-3 (FCRL3) locus in Caucasians with autoimmune disorders suggests a complex pattern of disease association. J Clin Endocrinol Metab 2007;92:1106-11. (Pubitemid 46465689)
11. Plant D, Barton A, Thomson W, Ke X, Eyre S, Hinks A, et al. A re-evaluation of three putative functional single nucleotide polymorphisms in rheumatoid arthritis. Ann Rheum Dis 2009;68:1373-5.
12. Newman WG, Zhang Q, Liu X, Walker E, Ternan H, Owen J, et al. Rheumatoid arthritis association with the FCRL3 -169C polymorphism is restricted to PTPN22 1858T-homozygous individuals in a Canadian population. Arthritis Rheum 2006;54:3820-7. (Pubitemid 44955883)
13. Begovich AB, Chang M, Schrodi SJ. Meta-analysis evidence of a differential risk of the FCRL3 -169T->C polymorphism in white and East Asian rheumatoid arthritis patients. Arthritis Rheum 2007;56:3168-71. (Pubitemid 47502766)
14. Lee YH, Woo JH, Choi SJ, Ji JD, Song GG. Fc receptor-like 3 -169 C/T polymorphism and RA susceptibility: a meta-analysis. Rheumatol Int 2010;30:947-53.
15. Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP, et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 2010;42:508-14.
16. Gibson AW, Li FJ, Wu J, Edberg JC, Su K, Cafardi J, et al. The FCRL3 -169CT promoter single-nucleotide polymorphism, which is associated with systemic lupus erythematosus in a Japanese population, predicts expression of receptor protein on CD19+B cells. Arthritis Rheum 2009;60:3510-2.
17. van der Linden MP, Feitsma AL, Le CS, Kern M, Olsson LM, Raychaudhuri S, et al. Association of a single-nucleotide polymorphism in CD40 with the rate of joint destruction in rheumatoid arthritis. Arthritis Rheum 2009;60:2242-7.
18. Lie BA, Viken MK, Odegard S, van der Heijde D, Landewe R, Uhlig T, et al. Associations between the PTPN22 1858C->T polymorphism and radiographic joint destruction in patients with rheumatoid arthritis: results from a 10-year longitudinal study. Ann Rheum Dis 2007;66:1604-9. (Pubitemid 350205448)
19. Scherer HU, van der Linden MP, Kurreeman FA, Stoeken-Rijsbergen G, Cessie S, Huizinga TW, et al. Association of the 6q23 region with the rate of joint destruction in rheumatoid arthritis. Ann Rheum Dis 2010;69:567-70.
20. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24. (Pubitemid 18091653)
21. Haugeberg G, Orstavik RE, Uhlig T, Falch JA, Halse JI, Kvien TK. Bone loss in patients with rheumatoid arthritis: results from a population-based cohort of 366 patients followed up for two years. Arthritis Rheum 2002;46:1720-8. (Pubitemid 34774502)
22. Syversen SW, Gaarder PI, Goll GL, Odegard S, Haavardsholm EA, Mowinckel P, et al. High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study. Ann Rheum Dis 2008;67:212-7. (Pubitemid 351183310)
23. van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 2000;27:261-3.
24. Odegard S, Landewe R, van der Heijde D, Kvien TK, Mowinckel P, Uhlig T. Association of early radiographic damage with impaired physical function in rheumatoid arthritis: a ten-year, longitudinal observational study in 238 patients. Arthritis Rheum 2006;54:68-75. (Pubitemid 43122188)
25. van der Helm-van Mil AH, Huizinga TW. Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets. Arthritis Res Ther 2008;10:205.
26. Takata Y, Inoue H, Sato A, Tsugawa K, Miyatake K, Hamada D, et al. Replication of reported genetic associations of PADI4, FCRL3, SLC22A4 and RUNX1 genes with rheumatoid arthritis: results of an independent Japanese population and evidence from meta-analysis of East Asian studies. J Hum Genet 2008;53:163-73.
27. Davis RS. Fc receptor-like molecules. Annu Rev Immunol 2007;25:525-60. (Pubitemid 46697916)
28. Davis RS, Wang YH, Kubagawa H, Cooper MD. Identification of a family of Fc receptor homologs with preferential B cell expression. Proc Natl Acad Sci USA 2001;98:9772-7. (Pubitemid 32769379)
29. Kochi Y, Myouzen K, Yamada R, Suzuki A, Kurosaki T, Nakamura Y, et al. FCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-cell receptor-mediated signaling. J Immunol 2009;183:5502-10.
30. Forslind K, Ahlmen M, Eberhardt K, Hafstrom I, Svensson B. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). Ann Rheum Dis 2004;63:1090-5. (Pubitemid 39120360)
31. Chen JY, Wang CM, Wu YJ, Kuo SN, Shiu CF, Chang SW, et al. Disease phenotypes and gender association of FCRL3 single-nucleotide polymorphism -169T/C in Taiwanese patients with systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol 2011;38:264-70.
32. Syversen SW, Goll GL, van der Heijde D, Landewe R, Gaarder PI, Odegard S, et al. Cartilage and bone biomarkers in rheumatoid arthritis: prediction of 10-year radiographic progression. J Rheumatol 2009;36:266-72.
33. Syversen SW, Goll GL, van der Heijde D, Landewe R, Lie BA, Odegard S, et al. Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study. Ann Rheum Dis 2010;69:345-51.